TY  - JOUR
AU  - Pérez-Ruiz, Elisabeth
AU  - Etxeberria, Iñaki
AU  - Rodriguez-Ruiz, Maria E
AU  - Melero, Ignacio
PY  - 2017
DO  - 10.1158/1078-0432.CCR-17-1799
UR  - https://hdl.handle.net/10668/26705
T2  - Clinical cancer research : an official journal of the American Association for Cancer Research
AB  - T-cell costimulation and coinhibition can be respectively exploited by blocking and agonist mAbs. Both strategies can be synergistically combined in mouse models. Early clinical results from combinations of anti-PD-1 mAbs in conjunction with agonist...
LA  - en
KW  - Antibodies, Monoclonal
KW  - Antineoplastic Agents, Immunological
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - B7-H1 Antigen
KW  - Clinical Trials, Phase I as Topic
KW  - Drug Synergism
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Neoplasms
KW  - Programmed Cell Death 1 Receptor
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor Receptor Superfamily, Member 9
TI  - Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy.
TY  - research article
VL  - 23
ER  -